Ningbo Cancer Hospital Report issue

Academic/Hospital Phase 2
Founded: Ningbo Shi China

Organization Overview

First Clinical Trial
2016
NCT02873416
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Neoplasms (Phase 2)

Stomach Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 3